Study of CD38 and CD56 in Chronic Myeloid Leukemia

Starting soon

Conditions studied: Chronic Myeloid Leukemia (CML)

In brief

Chronic myeloid leukemia is a myelo-proliferative neoplasm characterized by abnormal proliferation of myeloid cells. There is an accumulation of mature granulocytes in the blood and bone marrow. The aim of the study is to study expression of CD38 and CD56 in patients with Chronic myeloid leukemia.

Key facts

Study ID

NCT07740603

Run by

Sohag University

People needed

200

Starts

2026-09-01

Expected to finish

2027-07-01

Last updated by the study team

2026-08-05

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• patients with chronic myeloid leukemia

You may not qualify if…

• other hematological diseases

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.